Approval · Notice of Compliance 670 · 2002
PMS-MEDROXYPROGESTERONE: Notice of Compliance 670
Issued October 9, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 670
- Date
- October 9, 2002
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Progestagen
- Canadian reference product
- PROVERA (The Upjohn Company Of Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-MEDROXYPROGESTERONE | 02246627 | Cancelled Post Market |
| PMS-MEDROXYPROGESTERONE | 02246628 | Cancelled Post Market |
| PMS-MEDROXYPROGESTERONE | 02246629 | Cancelled Post Market |
Medicinal ingredients
- MEDROXYPROGESTERONE ACETATE 2.5 MG per TAB
- MEDROXYPROGESTERONE ACETATE 5 MG per TAB
- MEDROXYPROGESTERONE ACETATE 10 MG per TAB